We generally allow three months as standard revision time. As a matter of policy, competing manuscripts published during this period will not negatively impact on our assessment of the conceptual advance presented by your study. However, we request that you contact the editor as soon as possible upon publication of any related work, to discuss how to proceed. Should you foresee a problem in meeting this three-month deadline, please let us know in advance and we may be able to grant an extension.
Thank you for the opportunity to consider your work for publication. I look forward to your revision.
------------------------------------------------REFEREE COMMENTS
Referee #1
The paper from Hager's group presents data showing that C/EBP family proteins maintain chromatin assembly in liver and that C/EBPbeta facilitates recruitment of GR to chromatin. Using adrenalectomized mouse model, the authors identified glucocorticoid receptor (GR)-activated and repressed genes which correlated with RNA polymerase II occupancy. The 62% of the CR binding regions were also occupied by a member of C/EBP family C/EBPbeta. The authors found that C/EBPbeta binding serves as priming event in the recruitment of GR to the DNA regions. They also found that dominant negative C/EBP inhibits the GR recruitment to chromatin regions containing C/EBP sites. Based on these findings, the author suggest that selective targeting of GR in the liver is mediated by C/EBPbeta and that, in other tissues, cell-specific priming proteins might target GR to chromatin. These observations are novel and important for the field of liver biology. The paper presents convincing evidence which support the authors' conclusions. However, the manuscript needs some additional studies to confirm specificity of the priming proteins. Comments. 1. In the regions of GR binding, the authors identified highly enriched motifs for C/EBP, HNF4 and FOXA1 proteins and focused further studies on C/EBPbeta. Liver expresses two members of C/EBP family, C/EBPalpha and C/EBPbeta. Although the authors mentioned some data for C/EBPalpha, it is not clear if C/EBPalpha contributes to the GR recruitment to chromatin. It would be important to include more data for C/EBPalpha or present data with clear indication for the role of each protein.
2. The authors have discussed two groups of chromatin regions occupied by C/EBPbeta regarding possible direct or indirect bindings (page 11). It would be important to examine by experiments if C/EBPbeta directly binds to some of them using EMSA. This will make a better rationale for the authors' suggestions. 3. The GR-C/EBP occupancy correlates with both repression and activation of genes. It would help if the authors would discuss possible mechanisms based on literature data.
Referee #2
Grontved, et al. performed an extensive set of genomic experiments examining the connections between GR, C/EBP factors, and chromatin architecture. They demonstrate that GR binding sites can be divided into several major classes based on the chromatin state prior to GR activation, and the apparent mode of GR binding. Their conclusions are well supported by their data and represent an important contribution to the field of GR signaling and more broadly to the field of transcriptional regulation. My primary concerns, detailed below, relate to the lack of statistical tools applied to the ChIP-seq comparisons, and the insufficient attention given to changes in gene expression associated with the observed changes in binding and chromatin accessibility.
Major Concerns: 1) When dividing binding sites based on ChIP-seq data from two conditions, the authors use an arbitrary fold-change cutoff, which ignores the higher technical variation in tag counts at weaker sites. Several tools for comparing two ChIP-seq data sets in a statistically rigorous way are readily available, such as DiffBind (Ross-Innes, et al. Nature 2012) . At a minimum, the authors should apply this tool to their data to confirm that the majority of their site classifications show a statistically significant difference in each ChIP-seq experiment. This tool should also be used to confirm that the modest changes in GR binding and DHS observed in Figures 5E and 6C (the majority of which are less than 2-fold) can be called statistically significant.
2) Although the authors find general trends in the changes for GR binding and DHS-seq after disrupting C/EBP binding, they do not examine the impact on GR-dependent gene expression. This is especially critical to the conclusions of the paper, because the majority of ChIP-seq fold-changes observed after DN-C/EBP treatment are moderate (less than 2-fold) and may simply reflect noise in the ChIP-seq experiment. In figure 5F , the authors show that some dex-induced genes have reduced expression after DN-C/EBP treatment. However, the more relevant question is whether DN-C/EBP treatment affects the induction of genes by GR. The authors should test whether the dex/vehicle ratio of gene expression is altered by DN-C/EBP for this set of genes, or repeat their RNAPII ChIPseq experiment in the DN-C/EBP system. The authors should also examine if the effect of DN-C/EBP on dex-induced gene expression differs between preprogrammed and de novo GR sites, as the role of C/EBP is proposed to be different between these site classes.
Minor Concerns:
3) In the Discussion, the authors should compare their results to those reported in Uhlenhaut, et al. Mol Cell 2012, which also examines distinct classes of GR binding and their relative associations with both induced and repressed gene expression patterns.
4) While the occurrence of tethering between GR and C/EBP at specific site classes is a reasonable hypothesis based on the motif results, the authors have not conducted the necessary experiments to address this. They should either perform re-ChIP experiments to validate this, or reserve this claim for the discussion and clearly denote it as a hypothesis, not a conclusion based on their initial analysis. Figure 1E is not an appropriate type of plot given the large number of sites being examined. This should be a boxplot, as is used in later figures with similar data, to clearly show the overall distribution of fold-changes. 6) On page 9, line 24, there is a reference to Figure 3C , but the text actually describes the right half of Figure 3B . 7) On page 11, line 2, it is stated that "GR binding sites not bound by C/EBPb" correspond to "8% of the de novo GR binding sites", but it is clear from Figure 4A that this is not the case, as group 4 appears to be the majority of de novo GR sites.
5)

Referee #3
This manuscript is a comprehensive presentation of glucocorticoid receptor (GR) binding sites following activation by dexamethasone (Dex) in the livers of adrenalized mice where little or no endogenous glucocorticoid signaling takes place. Measurements of RNA PolII identify sites whose gene expression is altered by GR binding (accepting that PolII occupancy determines expression). The study demonstrates the interactions of GR and C/EBPb upon activation of GR by its ligand Dex. Although interactions between GR and C/EBP proteins have been described previously, this manuscript presents a global view of the process of GR binding and implicates C/EBPb as a major partner with GR in the liver; frequently occupying the site prior to GR binding and sometimes joining GR at the binding site after activation. The authors further show that DNA accessibility, as measured by DNAse hypersensitivity, is highly (62%) associated with occupancy of the DNA by C/EBPb and propose that C/EBPb has a "priming" function for GR binding. This is a novel finding that could only be generated by the global analysis carried out in this paper.
Data quality is excellent and the use of a dominant negative C/EBPb construct to substantiate the role of this transcription factor is clever and increases confidence in the observations regarding the role of C/EBPb.
Suggested changes:
Include information about total GR binding upon Dex treatment before presenting the information about the association with RNA PolII binding and DNase hypersensitive sites (DHS). The information on page 7 lines 31-35 makes the case that GR binding is strongly influenced by other epigenetic factors, which supports the approach of examining the DHS and integrating the studies of liver specific GR sites with "accessibility". Or perhaps provide a rationale in the Introduction regarding the need to correlate GR binding with RNA PolII and DHS. This is not a critical issue, but it would help the reader to appreciate the contextual properties of GR binding.
Indicate in the text or the figure legend (4S) what the criteria are for "distal" GR peaks.
In fig. 1A and 1B, include the browser path for GR treated with vehicle as is done in other figures throughout the paper. It is a critical control track.
In the legend for Figure 5 , line 26, I think it should read "that does NOT bind" Figure 5C is a bit hard to interpret. Would it help just to show the two overlapping histograms? We would like to thank the Referees for their insightful comments and suggestions for improving the manuscript. We have addressed all Referee comments with revisions to the text and figures. Additionally, we have included several new data sets and additional analysis to both the main and supplementary figures. Specifically we have included an extra main figure to address how GR is specifically recruited to C/EBPbeta binding sites when the canonical GR binding motif is absent (potential tethering sites).
In summary, all the Referees have commented on the importance of the study and the quality of the data, indicating that our study provides novel findings with importance to the fields of liver biology (Referee#1), GR signaling and more broadly to the field of transcriptional biology (Referee#2). Referee#3 indicated that data quality is excellent and the use of a dominant negative C/EBP construct to substantiate the role of this transcription factor is clever and increases confidence in the observations regarding the role of C/EBPbeta. Referee#3 also mentioned that this is a novel finding that could only be generated by the global analysis carried out in this paper.
To meet the requirement of 55,000 characters we have moved parts of the materials and methods to the supplementary material and shortened the introduction and discussion. _______________________________________________________
Referee #1
The paper from Hager's group presents data showing that C/EBP family proteins maintain chromatin assembly in liver and that C/EBPbeta facilitates recruitment of GR to chromatin. Using adrenalectomized mouse model, the authors identified glucocorticoid receptor (GR)-activated and repressed genes which correlated with RNA polymerase II occupancy. The 62% of the CR binding regions were also occupied by a member of C/EBP family C/EBPbeta. The authors found that C/EBPbeta binding serves as priming event in the recruitment of GR to the DNA regions. They also found that dominant negative C/EBP inhibits the GR recruitment to chromatin regions containing C/EBP sites. Based on these findings, the author suggest that selective targeting of GR in the liver is mediated by C/EBPbeta and that, in other tissues, cell-specific priming proteins might target GR to chromatin. These observations are novel and important for the field of liver biology. The paper presents convincing evidence which support the authors' conclusions. However, the manuscript needs some additional studies to confirm specificity of the priming proteins.
Comments.
1. In the regions of GR binding, the authors identified highly enriched motifs for C/EBP, HNF4 and FOXA1 proteins and focused further studies on C/EBPbeta. Liver expresses two members of C/EBP family, C/EBPalpha and C/EBPbeta. Although the authors mentioned some data for C/EBPalpha, it is not clear if C/EBPalpha contributes to the GR recruitment to chromatin. It would be important to include more data for C/EBPalpha or present data with clear indication for the role of each protein.
Response: We fully agree with Referee that C/EBPalpha is important to consider. In figure S7B we show that most if not all C/EBPbeta binding sites potentially are occupied by C/EBPalpha in adult mouse liver. C/EBPalpha and beta forms homo and heterodimers which likely occurs at most C/EBPalpha and beta binding sites in adult liver. Therefore to disrupt overall C/EBP binding to the genome, we used an approach to reduce all C/EBP subtype binding. We agree that it is important to show that the dominant negative C/EBP is also affecting C/EBPalpha binding at all regions monitored using site-selected ChIPs (see new figure 6B ).
2. The authors have discussed two groups of chromatin regions occupied by C/EBPbeta regarding possible direct or indirect bindings (page 11). It would be important to examine by experiments if C/EBPbeta directly binds to some of them using EMSA. This will make a better rationale for the authors' suggestions.
Response: The Referee raises an interesting idea: that is, can we recapitulate the in vivo GR and C/EBPbeta binding to composite and non-composite ('tethering') elements on defined DNA templates in vitro. The aim would be to resolve the different GR-C/EBP complexes (DNA-bound at composite elements versus 'tethering' to non-composite elements as different species in vitro).
However it raises of few technical concerns. For example the interaction between GR and other proteins known to tether GR (such as AP1) at non-composite sites has been shown to be complex, requiring co-factors such as Trip6 (Diefenbacher et al. 2008 , Mol Endocrinol. 22(8):1767 . Therefore, in vitro assembly of the C/EBP-GR complex with purified proteins might not be able to fully recapitulate 'tethering'. In addition, GR-C/EBP interactions at composite elements cannot be resolved into different species with full-length GR in gel shifts; instead, attempts to demonstrate tethering have resorted to the use of the DNA binding domain of GR (Pearce et al., 1998, JCB 273:30081-30085) . This limits the ability to recapitulate in vivo observations in vitro. Given the technical difficulties that would need to be hurdled to obtain purified C/EBP and GR, coupled with assembly in an in vitro chromatin system, we feel that this suggestion is beyond the scope of the current manuscript. We therefore explained in the text (page 10) that based on motif analysis C/EBPbeta may bind indirectly to DNA or to other non canonical C/EBP binding sites.
We have also looked more carefully at sites where GR binds C/EBPbeta binding sites without canonical GR motifs (new figure 5 and corresponding description page 11-12). From this analysis it appears that tethering is a rarer event than initially anticipated. Rather GR binding to these regions might occur through GR half sites, although the prospects for indirect binding of GR via tethering cannot be formally excluded since about 20% of pre-programmed GR binding sites occupied by C/EBPbeta do not have canonical GR binding sites and GR half sites ( figure 5D ).
3. The GR-C/EBP occupancy correlates with both repression and activation of genes. It would help if the authors would discuss possible mechanisms based on literature data.
Response: We thank the reviewer for pointing to this observation and we agree it must be addressed further in the discussion. It is known that GR interaction with transcription factors such AP1 (Biddie et al, Mol Cell. 2011 Jul 8; 43 (1):145-55), NF-kB (Uhlenhaut et al, Mol Cell. 2013 Jan 10;49(1):158-71.) and C/EBPbeta (here) frequently occurs near activated and repressed genes. A recent interesting report from the Evans lab suggests that it is not necessarily the cis-acting elements that directs the transcriptional outcome of nearby genes, but rather the combination with the chromatin structure and transcriptional co-regulators recruited (Uhlenhaut et al, Mol Cell. 2013 Jan 10;49(1):158-71.). We have extended our discussion to address this (page 16). Briefly, our findings agree well with those reported by Uhlenhaut et al. We show that GR is as frequently recruited to C/EBPbeta occupied chromatin near activated and repressed genes. When we integrate information on changes in chromatin structure (DNase-seq data) we demonstrate that induced chromatin accessibility at GR binding sites is specifically prevalent near activated genes compared to repressed genes. Also assisted loading of C/EBPbeta through transition in chromatin structure is specific for activated genes. In contrast repressed genes are associated with nearby regions of decreased chromatin accessibility. Thus the change in chromatin structure, and not necessarily the combination of transcription factors bound, dictates nearby gene transcription, emphasizing importance of integrating transcription factor ChIP-seq analysis with measurements of changes in chromatin configuration.
Referee #2
Major Concerns:
1) When dividing binding sites based on ChIP-seq data from two conditions, the authors use an arbitrary fold-change cutoff, which ignores the higher technical variation in tag counts at weaker sites. Several tools for comparing two ChIP-seq data sets in a statistically rigorous way are readily available, such as DiffBind (Ross-Innes, et al. Nature 2012). At a minimum, the authors should apply this tool to their data to confirm that the majority of their site classifications show a statistically significant difference in each ChIP-seq experiment.
Response: This is an important point raised by the Referee. For all ChIP-seq peak calling and DHS identification we applied software described in (Nat Genet. 2011 Mar;43(3):264-8 and Methods Mol Biol. 2012;833:433-41). This calculates replicate concordant ChIP peaks and DHS at most stringent FDR. We used an arbitrary fold cut off only for the RNAPII ChIP-seq data ( figure 1C and 1D ) and classification of differentially regulated DHS in figure 1E . To address the concerns of the Referee we have applied the DEseq statistical software package (Anders et al, Genome Biol. 2010;11(10):R106), which DiffBind also uses, to find differentially RNAPII bound genes in response to dex. We modified figure 1 accordingly. The number of dex regulated genes increased a little and we used the updated list of genes for new analysis shown in figure 1I , figure 1J , figure 4D . This resulted in very modest changes and the conclusion remains the same. We also applied DE-seq to identify the differentially dex regulated DHS. Instead of using a 2 fold cutoff we used p<0.05 for change of accessibility of DHS. Example can be found in new figure S4 . We modified figure 1E to highlight the difference of DHS accessibility at induced and repressed genes. Data supporting figure  1E can be found in new figure S4A and S4B. Also we made an analysis addressing how many of the dex differentially regulated genes that harbors DHS with increased and repressed accessibility (new figure S4C and S4D ). It is clear from this data that genes induced by dex have nearby regulatory sites with increased accessibility in response to dex. In contrast genes repressed by dex have nearby regulatory sites with decreased accessibility.
This tool should also be used to confirm that the modest changes in GR binding and DHS observed in Figures 5E and 6C (the majority of which are less than 2-fold) can be called statistically significant.
Response: We agree that expressing the DN-C/EBP only leads to modest changes of GR occupancy and chromatin accessibility. Since DN-C/EBP competes with endogenous C/EBP proteins it is difficult to obtain near complete knock down of C/EBP binding to chromatin. Often knock down can be improved by higher level of DN expression; however working with animals we were not able to inject higher titer of virus without compromising the health of the animal. Also recent ENCODE data (Thurman et al, Nature. 2012 Sep 6; 489(7414):75-82 and Neph et al, 2012 Sep 6; 489(7414) :83-90.) shows a linear relationship between TF occupancy and chromatin accessibility and that most DHSs are occupied by numerous TFs, up to 10 or 20. Thus transcription factor binding and chromatin accessibility are reflective of numerous proteins that contribute (additively or synergistically) to maintenance of accessibility. The depletion of a single protein will, therefore, compromise binding and accessibility only marginally. We believe that the achieved knockdown of C/EBP binding to chromatin is sufficient to show that C/EBP specifically disrupts GR binding to chromatin at sites where C/EBP is bound together with GR. Also we have seen similar effects using DN AP1 in cell lines (Biddie et al, Mol Cell. 2011 Jul 8; 43(1):145-55) . Since the general effect on GR occupancy and chromatin accessibility is specific at GR binding sites occupied by C/EBPbeta compared to sites not occupied by C/EBPbeta (figures 6E and 7C) we believe that it does not reflect noise in the ChIP and DHS experiments, but rather reflects biological relevance.
Response: As explained above we believe that the modest specific effect of DN-C/EBP on GR occupancy and chromatin accessibility shows that C/EBP regulates GR recruitment to chromatin in liver tissue. We agree that it is important to also show any effects on dex regulated gene expression. We performed a new set of experiments addressing this. Specifically, we injected animals with adenovirus expressing DN-C/EBP, performed adrenalactomy and injections with veh and dex. We subsequently probed for changes in gene expression of a subset of GR regulated genes and updated old figure 5E (moved to figure S9C ), now figure 6F and 6G. From the new figure 6F it can be seen that DN-C/EBP significantly affects expression of many GR target genes. However some genes remain unaffected ( figure 6G ). Thus co-occupancy of GR and C/EBPbeta near genes does not predict transcriptional co-regulation by GR and C/EBPbeta. As shown in figure 4D , most GR regulated genes are covered with nearby GR binding sites in presence and absence of C/EBPbeta. Currently we do not have sufficient experiential data to determine specifically which of the GR binding sites are important for expression of a given gene. Hence some genes may primarily be regulated by enhancers co-occupied by GR and C/EBPbeta, whereas other genes are sufficiently regulated by enhances where GR operates independently of C/EBPbeta. Also other epigenomic features besides TF binding, such as histone modifications and eRNA synthesis, may provide additional clues linking functional binding from opportunistic binding ( Response: We agree that it is important to discuss our findings in relations to the recent report from the Evans lab. We have incorporated the report from the Evans lab into the discussion (page 16). In summary our findings agree well with those reported by Uhlenhaut et al. They suggest that the combination of cis-acting elements correlates poorly with nearby activation or repression of genes. This emphasizes the importance of the epigenome. We see similar patterns when we look at GR-C/EBP interaction. When we integrate with chromatin accessibility data, we observe that dex activated genes have nearby regions with increased accessibility and dex repressed genes have nearby regions of decrease accessibility, showing that changes chromatin organization correlate strongly with hormone-dependent expression of proximal genes.
4) While the occurrence of tethering between GR and C/EBP at specific site classes is a reasonable hypothesis based on the motif results, the authors have not conducted the necessary experiments to address this. They should either perform re-ChIP experiments to validate this, or reserve this claim for the discussion and clearly denote it as a hypothesis, not a conclusion based on their initial analysis.
Response: We agree that the initial motif analysis is only a suggestion for possible tethering of GR to DNA bound C/EBPbeta and vice versa. If most GR binding to C/EBPbeta occupied chromatin (at sites where the canonical GR motif is absent) is through tethering, then a major question is how this is specific. In other words, why does GR not simply bind to all C/EBP sites? We have performed additional analysis to address this question (new figure 5 and corresponding description on page 11-12). Interestingly we find that C/EBPbeta sites (without canonical GR motifs) enriched for GR ChIP-seq tags are significantly enriched for GR half sites, suggesting that the half sites directs specificity and tethering might be a less frequent event. Also chromatin accessibility is very different between GR and C/EBPbeta co-bound sites compared to C/EBPbeta sites not bound by GR, emphasizing the importance of chromatin accessibility for GR occupancy of chromatin. Figure 1E is not an appropriate type of plot given the large number of sites being examined. This should be a boxplot, as is used in later figures with similar data, to clearly show the overall distribution of fold-changes.
5)
Response: We agree that a boxplot is more appropriate to show the distribution of fold changes. We have prepared a boxplot showing how accessibility of DHSs near induced and repressed genes are changed in response to dex (new figure S4E ).
6) On page 9, line 24, there is a reference to Figure 3C , but the text actually describes the right half of Figure 3B .
Response: Thank you for pointing to this error. Typo has been corrected. 7) On page 11, line 2, it is stated that "GR binding sites not bound by C/EBPb" correspond to "8% of the de novo GR binding sites", but it is clear from Figure 4A that this is not the case, as group 4 appears to be the majority of de novo GR sites.
Response: We thank the reviewer for finding this obvious mistake. We have corrected it to be "72% of the de novo GR binding sites".
Referee #3
Data quality is excellent and the use of a dominant negative C/EBP construct to substantiate the role of this transcription factor is clever and increases confidence in the observations regarding the role of C/EBPb.
Suggested changes:
Response: We thank the reviewer for an alternate structural presentation that also provides a logical flow of data. Given the increasing evidence from our lab and others of the importance of chromatin accessibility and genome organization in influencing TF binding and transcription, we would prefer to maintain the current layout.
Response: Again, we thank the referee for pointing out the omission of this relevant information. We have added the criteria to the old figure 4S (now figure 5S) legend. Also we updated the legend of figure 2S and 3S to include the same set of criteria.
Response: This important control track was missing in figure 1A and 1B. We have added the control track to figure 1A and 1B.
In the legend for Figure 5 , line 26, I think it should read "that does NOT bind"
Response: We have corrected the typo. Figure 5C is a bit hard to interpret. Would it help just to show the two overlapping histograms?
Response: To support the histogram shown in figure 6C (previous figure 5C ) we now have included a scatterplot in figure S9A . We believe this clearly illustrates the effect of DN-C/EBP on genome wide C/EBPbeta binding to chromatin. Thank you for submitting your revised manuscript for our consideration. I am pleased to inform you that in light of the re-review comments from one of the original referees (provided below), we are very happy to accept the paper for publication! Before transfer of your manuscript to our publisher, we would require modification of a few minor points.
-Please remember to add the data accession numbers for all high-throughput data sets.
-The Materials and Methods section should contain sufficient detail so that all experimental procedures can be repeated by others, in conjunction with cited references. Although additional information can be included in the supplement, it should not be of immediate importance for the understanding of the manuscript. Therefore, I would like to ask you to move some the supplemental Materials and Methods section into the main text. Our space limitations are only approximations, and it is more important that the experimental techniques are transparent. Please also include a section on the statistical methods used in your manuscript.
If you have any questions, please do not hesitate to contact me.
